IR

JP EN

About Us
About Us CEO Message Mission&Vision Regenerative Medicine Business Environment Leadership Company Profile
SanBio’s Strengths
SanBio’s Strengths SB623 Pipeline Delivering medical care
to a large number
of patients Large-scale Production
Technology World-Leading
Development Team
Media Inquiries
Medical institutions
and practitioners
Patients and
their families

About Us

About Us

Strengths

SanBio’s Strengths

R&D
- SB623
- Pipeline
Technology

News

NEWS

Info

2010.10.04

Dainippon Sumitomo Pharma and SanBio Collaborate on Cell Therapy for Stroke Recovery.

News

Dainippon Sumitomo Pharma and SanBio Collaborate on Cell Therapy for Stroke Recovery.

PRESS

Media Inquiries

IR

Shareholders and
investors

PATIENT / GENERAL

Patients and
their families

Under construction
(release date not yet determined)

MEDICAL PERSONNEL

Medical institutions
and practitioners

Under construction
(release date not yet determined)

CEO Message
Mission&Vision
Regenerative Medicine
Business Environment
Leadership
Company Profile

SanBio’s Strengths

R&D
- SB623
- Pipeline
Technology

Media Inquiries

Copyright© SanBio Co,Ltd. 2020. All Rights Reserved.